Cigarette Smoking BehaviorNCT05499520
Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women
A study testing Culturally Tailored Anti-Smoking Messages in people with Cigarette Smoking Behavior, run by Abramson Cancer Center at Penn Medicine at 1 site in United States.
Trial summary
Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and… Read more about this study
- Who is it for?
- Ages 18 to 30 yearsHealthy volunteers can take part
- Conditions the study is for
- Cigarette Smoking Behavior
- What is being tested?
- Culturally Tailored Anti-Smoking Messages
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 2,591 participants
- Where
- 1 siteUnited States
- Study dates
- 21 Sep 2022to 15 Aug 2023
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Ages 18-30
- Woman
- Identifies as a sexual minority (any sexual orientation other than heterosexual)
- Lives in the United States
- Able to take surveys in English
Who cannot join
- Under 18 or older than 30
- Men
- Heterosexual
- Lives outside the United States
- Unable to take the survey in English
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
About this study
Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.
Read the detailed description
This study will recruit 3000 young adult sexual minority women (SMW), ages 18-30 years, current smokers (n = 1500) and not current smokers (n = 1500). The study will determine the effects of varying the dose (single vs. multiple), and latency (immediate vs. delayed) of showing participants inoculation anti-smoking messages on smoking and quitting intentions. The study team hypothesize that the multiple exposures (vs. single), and delayed exposure (vs. immediate) will be associated with increased resistance to marketing, reduced smoking intention, and increased quitting intention. The study team will further explore the mechanisms of inoculation effects through emotions, beliefs, and attitudes towards tobacco companies. Participants will be asked to complete a baseline survey and then will receive an anti-smoking message in varying dosages based on the condition they are assigned with a control group receiving no message. Participants will then see a pro-smoking or threat message immediately, one week, or one month late, depending on the condition they were assigned.
- Conditions
- Cigarette Smoking Behavior
- Being tested
- Culturally Tailored Anti-Smoking Messages
- Medical subject headings
- Cigarette Smoking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Culturally Tailored Anti-Smoking MessagesOther
Anti-smoking messages will be administered online via a Qualtrics survey.
| Study group | Role | What they receive |
|---|---|---|
| Currently Smoking, No Message Condition | No intervention | Participants will receive no anti-smoking messages. They will receive the threat message during the baseline survey. Outcomes will be measured before and immediately after seeing the threat message, and at 1 month. |
| Currently Smoking, Single Message Immediate | Experimental | Participants will receive a single anti-smoking message followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking message and threat message, immediately after seeing the threat message, and at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Currently Smoking, Single Message 1 Week Delay | Experimental | Participants will receive a single anti-smoking message during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, immediately after seeing the threat message at 1 week, and at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Currently Smoking, Single Message 1 Month Delay | Experimental | Participants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, and immediately after seeing the threat message at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Currently Smoking, Single Message 1 Month Delay, Repeated Exposure | Experimental | Participants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of a single anti-smoking message at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking message at baseline and immediately after seeing the threat message at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Currently Smoking, Three Messages Immediate | Experimental | Participants will receive three anti-smoking messages, followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking messages and threat message, immediately after seeing the threat message, and at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Currently Smoking, Three Messages 1 Week Delay | Experimental | Participants will receive three anti-smoking messages during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, immediately after seeing the threat message at 1 week, and at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Currently Smoking, Three Messages 1 Month Delay | Experimental | Participants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, and immediately after seeing the threat message at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Currently Smoking, Three Messages 1 Month Delay Repeat Exposure | Experimental | Participants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of three anti-smoking messages at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking messages at baseline and immediately after seeing the threat message at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Not Currently Smoking, No Message Condition | No intervention | Participants will receive no anti-smoking messages. They will receive the threat message during the baseline survey. Outcomes will be measured before and immediately after seeing the threat message, and at 1 month. |
| Not Currently Smoking, Single Message Immediate | Experimental | Participants will receive a single anti-smoking message followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking message and threat message, immediately after seeing the threat message, and at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Not Currently Smoking, Single Message 1 Week Delay | Experimental | Participants will receive a single anti-smoking message during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, immediately after seeing the threat message at 1 week, and at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Not Currently Smoking, Single Message 1 Month Delay | Experimental | Participants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, and immediately after seeing the threat message at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Not Currently Smoking, Single Message 1 Month Delay, Repeated Exposure | Experimental | Participants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of a single anti-smoking message at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking message at baseline and immediately after seeing the threat message at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Not Currently Smoking, Three Messages Immediate | Experimental | Participants will receive three anti-smoking messages, followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking messages and threat message, immediately after seeing the threat message, and at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Not Currently Smoking, Three Messages 1 Week Delay | Experimental | Participants will receive three anti-smoking messages during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, immediately after seeing the threat message at 1 week, and at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Not Currently Smoking, Three Messages 1 Month Delay | Experimental | Participants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, and immediately after seeing the threat message at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
| Not Currently Smoking, Three Messages 1 Month Delay Repeat Exposure | Experimental | Participants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of three anti-smoking messages at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking messages at baseline and immediately after seeing the threat message at 1 month. Receives: Other: Culturally Tailored Anti-Smoking Messages |
What is being measured
The primary outcome is the main question the study is designed to answer.
Intention to Quit Smoking at Follow-up
We used a 4-item scale on intention to quit smoking at baseline and at follow-up (immediate, one-week and one-month) among current smokers only:
- I will make an effort to quit smoking in the next 30 days;
- I intend to quit smoking in the next 30 days;
- I expect to quit smoking in the next 30 days;
- How likely is it that you will quit smoking in the next 30 days. Responses ranged on 7-point Likert-like scales. Responses were summed to create a scale for intention to quit (range from 4-28), higher scores indicate higher intention to quit.
Measured: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Intention to Purchase Cigarettes
The Juster scale was used to measure intention to purchase cigarettes at baseline and at one-month follow-up.
Participants were asked, "How likely are you to purchase cigarettes in the next 6 months?" Responses ranged from 0=No chance, almost no chance (1 in 100) to 10=Certain, practically certain (99 in 100).
Higher values reflect higher intention to purchase.
Measured: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Susceptibility to Smoke Cigarettes
Susceptibility to smoke cigarettes were measured using four-items:
- Have you ever been curious about smoking a cigarette?
- Do you think you will smoke a cigarette in the next year?
- Do you think that you will try a cigarette soon?
- If one of your best friends were to offer you a cigarette, would you smoke it? Responses ranged on 4-point Likert-like scales.
Responses were summed to create a scale for susceptibility to smoke cigarettes (range from 0-12). This was only measured among participants who did not currently smoke.
Higher scores indicate increased susceptibility to smoke cigarettes.
Measured: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Secondary outcomes (3)
Receptivity to Marketing
Receptivity to marketing was measured using 2 items:
- Tobacco companies should have the same rights to advertise as other companies.
- Are you open to using or wearing something with a tobacco company logo or picture on it? Response options range from 1 (strongly agree) to 5 (strongly disagree)
The scale is a sum of the responses to these items, the scale ranges from 2 to 10, with lower scores indicating greater receptivity to marketing.
Measured: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Tobacco Industry Attitudes
Tobacco industry attitudes were measured using 3 items:
- I would like to see cigarette companies go out of business.
- I would not work for a cigarette company.
- How much do you like cigarette companies.
Response options for items 1 and 2 were from 1 (Strongly agree) to 5 (Strongly disagree). Response options for item 3 were from 1 (Dislike strongly) to 5 (Like strongly). Response options were summed across these 3 items to create the tobacco industry attitudes scale.
Values range from 3 to 15, with lower scores indicating stronger anti-industry sentiment.
Measured: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Tobacco Industry Beliefs
Industry beliefs were measured using 4 items:
Cigarette companies lie. Cigarette companies target teens to replace smokers who die. Cigarette companies deny that cigarettes cause cancer and other harmful diseases.
Cigarette companies deny that cigarettes are addictive.
Response options were from 1 (Strongly agree) to 5 (Strongly disagree).
Responses were summed across these 4 items to create the tobacco industry beliefs scale. Values ranges from 4 to 20, with lower scores indicating stronger anti-industry sentiment.
Measured: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Aug 2022
- Study start21 Sep 2022
- Primary completion5 Jul 2023
- Study completion15 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Cigarette Smoking BehaviorStudies of the same condition, open and under way.
- More trials run by Abramson Cancer Center at Penn MedicineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 2,591 participants (actual)
Sponsor and investigators
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI), Harvard School of Public Health (HSPH), Stanford University, Dana-Farber Cancer Institute, Fenway Community Health
- Responsible party
- Principal investigator, Andy Tan, Abramson Cancer Center at Penn Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05499520
- Sponsor's protocol ID
- 11022
- Other IDs
- R01CA237670
- Status last verified
- Jul 2024
- First submitted
- 4 Aug 2022
- Last updated
- 31 Jul 2024
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women
- ClinicalTrials.gov ID
- NCT05499520
- Acronym / sponsor ID
- 11022
- Conditions
- Cigarette Smoking Behavior
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 2,591 participants (actual)
- Lead sponsor
- Abramson Cancer Center at Penn MedicineUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI), Harvard School of Public Health (HSPH), Stanford University, Dana-Farber Cancer Institute, Fenway Community Health
- Study start
- 21 Sep 2022 (actual)
- Primary completion
- 5 Jul 2023 (actual)
- Study completion
- 15 Aug 2023 (actual)
- First posted
- 12 Aug 2022 (actual)
- Results
- Posted 31 Jul 2024
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.
Detailed description
This study will recruit 3000 young adult sexual minority women (SMW), ages 18-30 years, current smokers (n = 1500) and not current smokers (n = 1500). The study will determine the effects of varying the dose (single vs. multiple), and latency (immediate vs. delayed) of showing participants inoculation anti-smoking messages on smoking and quitting intentions. The study team hypothesize that the multiple exposures (vs. single), and delayed exposure (vs. immediate) will be associated with increased resistance to marketing, reduced smoking intention, and increased quitting intention. The study team will further explore the mechanisms of inoculation effects through emotions, beliefs, and attitudes towards tobacco companies. Participants will be asked to complete a baseline survey and then will receive an anti-smoking message in varying dosages based on the condition they are assigned with a control group receiving no message. Participants will then see a pro-smoking or threat message immediately, one week, or one month late, depending on the condition they were assigned.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Single blind (participant)
- Number of arms
- 18
| Arm | Type | Receives |
|---|---|---|
| Currently Smoking, No Message Condition | No intervention | –Participants will receive no anti-smoking messages. They will receive the threat message during the baseline survey. Outcomes will be measured before and immediately after seeing the threat message, and at 1 month. |
| Currently Smoking, Single Message Immediate | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive a single anti-smoking message followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking message and threat message, immediately after seeing the threat message, and at 1 month. |
| Currently Smoking, Single Message 1 Week Delay | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive a single anti-smoking message during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, immediately after seeing the threat message at 1 week, and at 1 month. |
| Currently Smoking, Single Message 1 Month Delay | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, and immediately after seeing the threat message at 1 month. |
| Currently Smoking, Single Message 1 Month Delay, Repeated Exposure | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of a single anti-smoking message at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking message at baseline and immediately after seeing the threat message at 1 month. |
| Currently Smoking, Three Messages Immediate | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive three anti-smoking messages, followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking messages and threat message, immediately after seeing the threat message, and at 1 month. |
| Currently Smoking, Three Messages 1 Week Delay | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive three anti-smoking messages during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, immediately after seeing the threat message at 1 week, and at 1 month. |
| Currently Smoking, Three Messages 1 Month Delay | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, and immediately after seeing the threat message at 1 month. |
| Currently Smoking, Three Messages 1 Month Delay Repeat Exposure | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of three anti-smoking messages at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking messages at baseline and immediately after seeing the threat message at 1 month. |
| Not Currently Smoking, No Message Condition | No intervention | –Participants will receive no anti-smoking messages. They will receive the threat message during the baseline survey. Outcomes will be measured before and immediately after seeing the threat message, and at 1 month. |
| Not Currently Smoking, Single Message Immediate | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive a single anti-smoking message followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking message and threat message, immediately after seeing the threat message, and at 1 month. |
| Not Currently Smoking, Single Message 1 Week Delay | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive a single anti-smoking message during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, immediately after seeing the threat message at 1 week, and at 1 month. |
| Not Currently Smoking, Single Message 1 Month Delay | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, and immediately after seeing the threat message at 1 month. |
| Not Currently Smoking, Single Message 1 Month Delay, Repeated Exposure | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of a single anti-smoking message at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking message at baseline and immediately after seeing the threat message at 1 month. |
| Not Currently Smoking, Three Messages Immediate | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive three anti-smoking messages, followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking messages and threat message, immediately after seeing the threat message, and at 1 month. |
| Not Currently Smoking, Three Messages 1 Week Delay | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive three anti-smoking messages during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, immediately after seeing the threat message at 1 week, and at 1 month. |
| Not Currently Smoking, Three Messages 1 Month Delay | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, and immediately after seeing the threat message at 1 month. |
| Not Currently Smoking, Three Messages 1 Month Delay Repeat Exposure | Experimental | Other: Culturally Tailored Anti-Smoking MessagesParticipants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of three anti-smoking messages at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking messages at baseline and immediately after seeing the threat message at 1 month. |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Ages 18-30
- Woman
- Identifies as a sexual minority (any sexual orientation other than heterosexual)
- Lives in the United States
- Able to take surveys in English
Key exclusion criteria (5 listed)
- Under 18 or older than 30
- Men
- Heterosexual
- Lives outside the United States
- Unable to take the survey in English
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Culturally Tailored Anti-Smoking MessagesAnti-smoking messages will be administered online via a Qualtrics survey. | Other | Currently Smoking, Single Message 1 Month Delay, Currently Smoking, Single Message 1 Month Delay, Repeated Exposure, Currently Smoking, Single Message 1 Week Delay, Currently Smoking, Single Message Immediate, Currently Smoking, Three Messages 1 Month Delay, Currently Smoking, Three Messages 1 Month Delay Repeat Exposure, Currently Smoking, Three Messages 1 Week Delay, Currently Smoking, Three Messages Immediate, Not Currently Smoking, Single Message 1 Month Delay, Not Currently Smoking, Single Message 1 Month Delay, Repeated Exposure, Not Currently Smoking, Single Message 1 Week Delay, Not Currently Smoking, Single Message Immediate, Not Currently Smoking, Three Messages 1 Month Delay, Not Currently Smoking, Three Messages 1 Month Delay Repeat Exposure, Not Currently Smoking, Three Messages 1 Week Delay, Not Currently Smoking, Three Messages Immediate |
Primary outcome
Intention to Quit Smoking at Follow-up
Time frame: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
We used a 4-item scale on intention to quit smoking at baseline and at follow-up (immediate, one-week and one-month) among current smokers only: 1. I will make an effort to quit smoking in the next 30 days; 2. I intend to quit smoking in the next 30 days; 3. I expect to quit smoking in the next 30 days; 4. How likely is it that you will quit smoking in the next 30 days. Responses ranged on 7-point Likert-like scales. Responses were summed to create a scale for intention to quit (range from 4-28), higher scores indicate higher intention to quit.
Intention to Purchase Cigarettes
Time frame: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
The Juster scale was used to measure intention to purchase cigarettes at baseline and at one-month follow-up. Participants were asked, "How likely are you to purchase cigarettes in the next 6 months?" Responses ranged from 0=No chance, almost no chance (1 in 100) to 10=Certain, practically certain (99 in 100). Higher values reflect higher intention to purchase.
Susceptibility to Smoke Cigarettes
Time frame: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Susceptibility to smoke cigarettes were measured using four-items: 1. Have you ever been curious about smoking a cigarette? 2. Do you think you will smoke a cigarette in the next year? 3. Do you think that you will try a cigarette soon? 4. If one of your best friends were to offer you a cigarette, would you smoke it? Responses ranged on 4-point Likert-like scales. Responses were summed to create a scale for susceptibility to smoke cigarettes (range from 0-12). This was only measured among participants who did not currently smoke. Higher scores indicate increased susceptibility to smoke cigarettes.
3 secondary outcomes
Receptivity to Marketing
Time frame: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Tobacco Industry Attitudes
Time frame: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Tobacco Industry Beliefs
Time frame: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jul 2024.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Cigarette Smoking Behavior
Active, not recruiting
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Not yet recruiting
Impacto 2.0: Mobile Smoking Cessation Across Texas
Cigarette Smoking, Smoking Cessation
RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Smoking Cessation
Active, not recruiting
Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants
Smoking
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Culturally Tailored Anti-Smoking Messages in people with Cigarette Smoking Behavior, run by Abramson Cancer Center at Penn Medicine at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 31 Jul 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Intention to Quit Smoking at Follow-up (time frame: Day [0] reported for No-message, single-message immediate, & 3-messages immediate conditions; Week [1] reported for Single-message & 3-messages 1-week delay conditions; Month [1] reported for Single-message & 3-messages 1-month delay conditions). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2024.